Final Analysis of a Phase II Study of Modified FOLFIRINOX in Locally Advanced and Metastatic Pancreatic Cancer

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2016.45
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

A Patient-Level Meta-Analysis of FOLFIRINOX for Locally Advanced Pancreatic Cancer

HPB
HepatologyGastroenterology
2016English

Folfirinox Neoadjuvant Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer - A Retrospective Study

International Journal of Contemporary Medical Research [IJCMR]
2019English

Resectability After Neoadjuvant FOLFIRINOX in Locally Advanced Pancreatic Cancer: A Single-Center Experience

HPB
HepatologyGastroenterology
2016English

Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis

Oncologist
Cancer ResearchMedicineOncology
2019English

A Phase II Study of Carboplatin in Advanced or Metastatic Stomach Cancer

European Journal of Cancer and Clinical Oncology
1987English

A Phase-Ii Study of Combination of Pegylated Interferon Alfa-2a and Capecitabine in Locally Advanced or Metastatic Renal Cell Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2009English

Systematic Review of FOLFIRINOX in Patients With Locally Unresectable Pancreatic Cancer

HPB
HepatologyGastroenterology
2016English

The Benefits of Modified FOLFIRINOX for Advanced Pancreatic Cancer and Its Induced Adverse Events: A Systematic Review and Meta-Analysis

Scientific Reports
Multidisciplinary
2018English

Phase II Trial of Gemcitabine and Tanespimycin (17AAG) in Metastatic Pancreatic Cancer: A Mayo Clinic Phase II Consortium Study

Investigational New Drugs
OncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy